First Allied Advisory Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $480K | Sell |
8,700
-3,600
| -29% | -$199K | 0.02% | 720 |
|
|
2020
Q2 | $776K | Buy |
12,300
+7,368
| +149% | +$465K | 0.03% | 518 |
|
|
2020
Q1 | $252K | Buy |
4,932
+432
| +10% | +$22.1K | 0.01% | 833 |
|
|
2019
Q4 | $358K | Buy |
+4,500
| New | +$358K | 0.01% | 846 |
|
|
2019
Q2 | – | Sell |
-3,950
| Closed | -$208K | – | 1251 |
|
|
2019
Q1 | $208K | Sell |
3,950
-1,200
| -23% | -$63.2K | 0.01% | 1037 |
|
|
2018
Q4 | $211K | Sell |
5,150
-4,600
| -47% | -$188K | 0.01% | 935 |
|
|
2018
Q3 | $371K | Buy |
9,750
+1,800
| +23% | +$68.5K | 0.01% | 820 |
|
|
2018
Q2 | $359K | Buy |
7,950
+1,400
| +21% | +$63.2K | 0.01% | 809 |
|
|
2018
Q1 | $317K | Sell |
6,550
-775
| -11% | -$37.5K | 0.01% | 845 |
|
|
2017
Q4 | $288K | Buy |
+7,325
| New | +$288K | 0.01% | 895 |
|